Skip to main content

and
  1. Article

    Open Access

    A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics

    Abiraterone acetate is used at a fixed oral dose of 1000 mg once daily (OD) taken fasted. By administering abiraterone acetate with food, a reduced dose can potentially be given while maintaining equivalent ab...

    Floor J. E. Lubberman, Guillemette E. Benoist in Cancer Chemotherapy and Pharmacology (2019)

  2. Article

    Open Access

    31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

    Sonja Althammer, Keith Steele, Marlon Rebelatto in Journal for ImmunoTherapy of Cancer (2016)

  3. Article

    Open Access

    Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition

    Melanoma is the most lethal type of skin cancer and its incidence is progressively increasing. The introductions of immunotherapy and targeted therapies have tremendously improved the treatment of melanoma. Se...

    Jurjen Tel, Rutger Koornstra, Nienke de Haas in Journal of Translational Medicine (2016)

  4. No Access

    Article

    Therapeutic vaccines for cancer: an overview of clinical trials

  5. Development of vaccines for the treatment of cancer has posed many challenges, but results from some recent studies have confirmed the potential for clinical b...

  6. Ignacio Melero, Gustav Gaudernack, Winald Gerritsen in Nature Reviews Clinical Oncology (2014)

  7. No Access

    Article

    Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

    Studies on bladder cancer cell lines have shown that low adenoviral (Ad) infectivity is associated with low-level coxsackie adenovirus receptor (CAR) expression. Recently, we and others demonstrated a tumor st...

    Markus D Sachs, Meera Ramamurthy, Henk van der Poel in Cancer Gene Therapy (2004)